Loading clinical trials...

Targeting Attention Orienting to Social Threat to Reduce Social Anxiety in Youth | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITINGNA

Targeting Attention Orienting to Social Threat to Reduce Social Anxiety in Youth

NCT03932032•Florida International University

Summary

This two-site study is a test of Attention Bias Modification Treatment (ABMT) among 260 youths ages 10 to 14 years with social anxiety disorder. One-half of participants will receive 8 sessions of computer administered ABMT and the other half of participants will receive 8 sessions of computer administered Neutral Control Task (NCT). The investigators hypothesize that a biomarker of attention to social threat measured using electroencephalography (EEG) and ratings of social anxiety severity will be lower in participants who receive ABMT compared to participants who receive NCT.

Eligibility

Age

10 - 14 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Be between ages 10 and 14 years
•meet DSM5 criteria for a diagnosis of Social Anxiety Disorder
•presence of any coexisting psychiatric diagnoses must be of lesser severity than Social Anxiety Disorder
•have no current psychotropic medication other than a stable dose of stimulant or non-stimulant medication for coexisting ADHD

Exclusion Criteria

•meet DSM5 criteria for Autism Spectrum Disorder, Intellectual Disability, Bipolar Disorder, Tourette's Disorder, Psychotic Disorders, or Substance Use Disorders
•show high likelihood of hurting self or others
•be a victim of undisclosed abuse requiring investigation/ supervision by the Department of Social Services
•have an uncorrected vision or physical disability that interferes with the ability to click a mouse button rapidly and repeatedly
•have a history of neurological illness, including seizures/epilepsy, or head injury with loss of consciousness \> 5 minutes

Locations (2)

Yale Child Study Center Program for Anxiety and Mood Disorders

New Haven, Connecticut, United States

Florida International University Center for Children and Families

Miami, Florida, United States

Key Dates

Start Date

July 1, 2019

Primary Completion Date

March 31, 2026

Completion Date

March 31, 2026

Last Updated

May 1, 2025

Enrollment

260

ESTIMATED participants

Conditions

Social Anxiety Disorder of Childhood

Interventions

Attention Bias Modification Treatment

BEHAVIORAL

Neutral Control Task

BEHAVIORAL

Intervention Social Anxiety: Combining Parent-child Treatment

NCT06352463

Social Anxiety Disorder of Childhood

View study

ACTIVE_NOT_RECRUITINGNA

Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder

NCT05967468

Obsessive-Compulsive Disorder in ChildrenAnxiety Disorder of Childhood+7 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions